{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T03:20:25Z","timestamp":1787541625352,"version":"build-2736575974"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Youth Science Foundation Project of Gansu Provincial Hospital","award":["25GSSYB-15"],"award-info":[{"award-number":["25GSSYB-15"]}]},{"DOI":"10.13039\/501100004775","name":"Natural Science Foundation of Gansu Province","doi-asserted-by":"publisher","award":["22JR11RA252"],"award-info":[{"award-number":["22JR11RA252"]}],"id":[{"id":"10.13039\/501100004775","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82160588"],"award-info":[{"award-number":["82160588"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s10620-026-09844-3","type":"journal-article","created":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T16:28:45Z","timestamp":1774974525000},"page":"3700-3708","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The Carcinogenic Role of HMGB1 and NF-\u03baB in Gastric Adenocarcinoma"],"prefix":"10.1007","volume":"71","author":[{"given":"Zhiang","family":"Pan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingzhi","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jichun","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongjun","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingxu","family":"Da","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaoqi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,31]]},"reference":[{"key":"9844_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: a cancer journal for clinicians 2024;74:229\u2013263.","journal-title":"CA: a cancer journal for clinicians"},{"key":"9844_CR2","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.3390\/cancers16091708","volume":"16","author":"C Burz","year":"2024","unstructured":"Burz C, Pop V, Silaghi C, Lupan I, Samasca G. Prognosis and treatment of gastric cancer: a 2024 update. Cancers (Basel). 2024;16:1708.","journal-title":"Cancers (Basel)."},{"key":"9844_CR3","doi-asserted-by":"publisher","first-page":"1016817","DOI":"10.3389\/fimmu.2022.1016817","volume":"13","author":"Y Liu","year":"2022","unstructured":"Liu Y, Li C, Lu Y, Liu C, Yang W. Tumor microenvironment-mediated immune tolerance in development and treatment of gastric cancer. Frontiers in immunology 2022;13:1016817.","journal-title":"Frontiers in immunology"},{"key":"9844_CR4","doi-asserted-by":"publisher","first-page":"216494","DOI":"10.1016\/j.canlet.2023.216494","volume":"581","author":"R Chen","year":"2024","unstructured":"Chen R, Zou J, Zhong X, Li J, Kang R, Tang D. HMGB1 in the interplay between autophagy and apoptosis in cancer. Cancer letters 2024;581:216494.","journal-title":"Cancer letters"},{"key":"9844_CR5","doi-asserted-by":"publisher","first-page":"S6","DOI":"10.2119\/molmed.2015.00087","volume":"21","author":"H Yang","year":"2015","unstructured":"Yang H, Wang H, Chavan SS, Andersson U. High mobility group box protein 1 (hmgb1): the prototypical endogenous danger molecule. Molecular medicine 2015;21:S6\u2013S12.","journal-title":"Molecular medicine"},{"key":"9844_CR6","doi-asserted-by":"publisher","first-page":"1649366","DOI":"10.3389\/fimmu.2025.1649366","volume":"4","author":"L Li","year":"2025","unstructured":"Li L, Wang J, Huang L, Chen Y, Chen L. Inhibition of HMGB1\/NF-\u03baB signaling restores Th17\/Treg balance via dendritic cell modulation in liver transplant rejection. Front Immunol. 2025;4:1649366.","journal-title":"Front Immunol."},{"key":"9844_CR7","doi-asserted-by":"publisher","first-page":"1600596","DOI":"10.3389\/fcell.2025.1600596","volume":"4","author":"L Yang","year":"2025","unstructured":"Yang L, Li X, Zhu X, Ge F, Wang Y. Involvement of role of HMGB1-NLRP3 pathway in systemic disorders. Front Cell Dev Biol. 2025;4:1600596.","journal-title":"Front Cell Dev Biol."},{"key":"9844_CR8","doi-asserted-by":"publisher","first-page":"1593157","DOI":"10.3389\/fonc.2025.1593157","volume":"3","author":"D Li","year":"2025","unstructured":"Li D, Lei X, Zhao L, Fu Q, Chen Y, Yang X. Mechanism of action of HMGB1 in urologic malignancies. Front Oncol. 2025;3:1593157.","journal-title":"Front Oncol."},{"key":"9844_CR9","doi-asserted-by":"publisher","first-page":"5299","DOI":"10.1038\/onc.2010.261","volume":"29","author":"D Tang","year":"2010","unstructured":"Tang D, Kang R, Cheh CW, Livesey KM, Liang X, Schapiro NE et al. HMGB1 release and redox regulates autophagy and apoptosis in cancer cells. Oncogene. 2010;29:5299\u20135310.","journal-title":"Oncogene."},{"key":"9844_CR10","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2307999120","volume":"120","author":"JS Suarez","year":"2023","unstructured":"Suarez JS, Novelli F, Goto K, Ehara M, Steele M, Kim JH et al. HMGB1 released by mesothelial cells drives the development of asbestos-induced mesothelioma. Proc Natl Acad Sci U S A. 2023;120:e2307999120.","journal-title":"Proc Natl Acad Sci U S A."},{"key":"9844_CR11","doi-asserted-by":"publisher","DOI":"10.1097\/HC9.0000000000000311","volume":"7","author":"D Athavale","year":"2023","unstructured":"Athavale D, Barahona I, Song Z, Desert R, Chen W, Han H et al. Overexpression of HMGB1 in hepatocytes accelerates PTEN inactivation-induced liver cancer. Hepatol Commun. 2023;7:e0311.","journal-title":"Hepatol Commun."},{"key":"9844_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.labinv.2022.100054","volume":"103","author":"C Hou","year":"2023","unstructured":"Hou C, Lu M, Lei Z, Dai S, Chen W, Du S et al. HMGB1 positive feedback loop between cancer cells and tumor-associated macrophages promotes osteosarcoma migration and invasion. Lab Invest. 2023;103:100054.","journal-title":"Lab Invest."},{"key":"9844_CR13","doi-asserted-by":"publisher","first-page":"1529756","DOI":"10.3389\/fimmu.2025.1529756","volume":"16","author":"J Kaszycki","year":"2025","unstructured":"Kaszycki J, Kim M. Epigenetic regulation of transcription factors involved in NLRP3 inflammasome and NF-kB signaling pathways. Front Immunol. 2025;16:1529756.","journal-title":"Front Immunol."},{"key":"9844_CR14","doi-asserted-by":"publisher","first-page":"645","DOI":"10.3390\/jpm14060645","volume":"14","author":"YJ Park","year":"2024","unstructured":"Park YJ, Bae J, Yoo JK, Ahn SH, Park SY, Kim YS et al. Effects of NF-\u03baB inhibitor on sepsis depend on the severity and phase of the animal sepsis model. J Pers Med. 2024;14:645.","journal-title":"J Pers Med."},{"key":"9844_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.655887","volume":"10","author":"VQ Nguyen","year":"2021","unstructured":"Nguyen VQ, Eden K, Morrison HA, Sammons MB, Knight KK, Sorrentino S et al. Noncanonical NF-\u03baB signaling upregulation in inflammatory bowel disease patients is associated with loss of response to Anti-TNF agents. Front Pharmacol. 2021;10:655887.","journal-title":"Front Pharmacol."},{"key":"9844_CR16","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s43556-024-00207-w","volume":"5","author":"Y Liang","year":"2024","unstructured":"Liang Y, Li Y, Lee C, Yu Z, Chen C, Liang C. Ulcerative colitis: molecular insights and intervention therapy. Mol Biomed. 2024;5:42.","journal-title":"Mol Biomed."},{"key":"9844_CR17","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1186\/s40001-024-02168-w","volume":"29","author":"A Bahrami","year":"2024","unstructured":"Bahrami A, Khalaji A, BahriNajafi M, Sadati S, Raisi A, Abolhassani A, Eshraghi R, KhaksaryMahabady M, Rahimian N, Mirzaei H. NF-\u03baB pathway and angiogenesis: insights into colorectal cancer development and therapeutic targets. Eur J Med Res. 2024;29:610.","journal-title":"Eur J Med Res."},{"key":"9844_CR18","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1172\/JCI11914","volume":"107","author":"Y Yamamoto","year":"2001","unstructured":"Yamamoto Y, Gaynor RB. Therapeutic potential of inhibition of the NF-kappaB pathway in the treatment of inflammation and cancer. J Clin Invest. 2001;107:135\u2013142.","journal-title":"J Clin Invest."},{"key":"9844_CR19","doi-asserted-by":"publisher","first-page":"488","DOI":"10.3390\/cells14070488.PMID:40214442;PMCID:PMC11987742","volume":"14","author":"A Nishida","year":"2025","unstructured":"Nishida A, Andoh A. The role of inflammation in cancer: mechanisms of tumor initiation, progression, and metastasis. Cells. 2025;14:488.\u00a0","journal-title":"Cells."},{"key":"9844_CR20","doi-asserted-by":"publisher","first-page":"2519703","DOI":"10.1080\/19490976.2025.2519703","volume":"17","author":"V Arr\u00e8","year":"2025","unstructured":"Arr\u00e8 V, De Luca R, Mrmi\u0107 S, Marotta S, Nardone S, Incerpi S et al. Gastrointestinal inflammation and cancer: viral and bacterial interplay. Gut Microbes. 2025;17:2519703.","journal-title":"Gut Microbes."},{"key":"9844_CR21","doi-asserted-by":"publisher","first-page":"4413","DOI":"10.3390\/molecules28114413","volume":"28","author":"SS Sohrab","year":"2023","unstructured":"Sohrab SS, Raj R, Nagar A, Hawthorne S, Paiva-Santos AC, Kamal MA et al. Chronic inflammation\u2019s transformation to cancer: a nanotherapeutic paradigm. Molecules. 2023;28:4413.","journal-title":"Molecules."},{"key":"9844_CR22","doi-asserted-by":"publisher","first-page":"1601501","DOI":"10.3389\/fcimb.2025.1601501","volume":"27","author":"Z He","year":"2025","unstructured":"He Z, Zhou Y, Liu J, Li N, Fan H. The intersection of Helicobacter pylori and gastric cancer: signaling pathways and molecular mechanisms. Front Cell Infect Microbiol. 2025;27:1601501.\u00a0","journal-title":"Front Cell Infect Microbiol."},{"key":"9844_CR23","doi-asserted-by":"publisher","first-page":"1384109","DOI":"10.3389\/fonc.2024.1384109","volume":"25","author":"G Lv","year":"2024","unstructured":"Lv G, Yang M, Gai K, Jia Q, Wang Z, Wang B et al. Multiple functions of HMGB1 in cancer. Front Oncol. 2024;25:1384109.","journal-title":"Front Oncol."},{"key":"9844_CR24","doi-asserted-by":"publisher","first-page":"3893","DOI":"10.7150\/jca.42944","volume":"11","author":"Y Song","year":"2020","unstructured":"Song Y, Zou X, Zhang D, Liu S, Duan Z, Liu L. Self-enforcing HMGB1\/NF-\u03baB\/HIF-1\u03b1 feedback loop promotes cisplatin resistance in hepatocellular carcinoma cells. J Cancer. 2020;11:3893\u20133902.","journal-title":"J Cancer."},{"key":"9844_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.599124","volume":"4","author":"W Zhu","year":"2021","unstructured":"Zhu W, Li J, Zhang Y, Zhu Z, Liu H, Lin Y et al. Inhibition of HMGB1 suppresses hepatocellular carcinoma progression via HIPK2-mediated autophagic degradation of ZEB1. Front Oncol. 2021;4:599124.","journal-title":"Front Oncol."},{"key":"9844_CR26","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1089\/dna.2010.1107","volume":"30","author":"Y Fan","year":"2011","unstructured":"Fan Y, Yu W, Ye P, Wang H, Wang Z, Meng Q, Duan Y, Liang X, An W. NFKB1 insertion\/deletion promoter polymorphism increases the risk of advanced ovarian cancer in a Chinese population. DNA Cell Biol. 2011;30:241\u2013245.","journal-title":"DNA Cell Biol."},{"key":"9844_CR27","doi-asserted-by":"publisher","first-page":"8273","DOI":"10.4238\/2015.July.27.15","volume":"14","author":"LP Chen","year":"2015","unstructured":"Chen LP, Cai PS, Liang HB. Association of the genetic polymorphisms of NFKB1 with susceptibility to ovarian cancer. Genet Mol Res. 2015;14:8273\u20138282.","journal-title":"Genet Mol Res."},{"key":"9844_CR28","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/nri.2017.142","volume":"18","author":"K Taniguchi","year":"2018","unstructured":"Taniguchi K, Karin M. NF-\u03baB, inflammation, immunity and cancer: coming of age. Nat Rev Immunol. 2018;18:309\u2013324.","journal-title":"Nat Rev Immunol."},{"key":"9844_CR29","doi-asserted-by":"publisher","first-page":"4072","DOI":"10.7150\/jca.95339","volume":"15","author":"J Li","year":"2024","unstructured":"Li J, Wu Z, Pan Y, Chen Y, Chu J, Cong Y, Fang Q. GNL3L exhibits pro-tumor activities via NF-\u03baB pathway as a poor prognostic factor in acute myeloid leukemia. J Cancer. 2024;15:4072\u20134080.","journal-title":"J Cancer."},{"key":"9844_CR30","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.71317","volume":"14","author":"Y Chen","year":"2025","unstructured":"Chen Y, Bai M, Liu M, Zhang Z, Jiang C, Li K, Chen Y, Xu Y, Wu L. Metabolic reprogramming in lung cancer: hallmarks, mechanisms, and targeted strategies to overcome immune resistance. Cancer Med. 2025;14:e71317.","journal-title":"Cancer Med."},{"key":"9844_CR31","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1007\/s12672-025-02811-w","volume":"16","author":"Y Chen","year":"2025","unstructured":"Chen Y, Anwar M, Wang X, Zhang B, Ma B. Integrative transcriptomic and single-cell analysis reveals IL27RA as a key immune regulator and therapeutic indicator in breast cancer. Discov Oncol. 2025;16:977.","journal-title":"Discov Oncol."},{"key":"9844_CR32","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1007\/s12672-025-03068-z","volume":"16","author":"B Li","year":"2025","unstructured":"Li B, Lin R, Hua Y, Ma B, Chen Y. Single-cell RNA sequencing reveals TMEM71 as an immunomodulatory biomarker predicting immune checkpoint blockade response in breast cancer. Discov Oncol. 2025;16:1256.","journal-title":"Discov Oncol."},{"key":"9844_CR33","doi-asserted-by":"crossref","unstructured":"Zhang, B., Lau, L.Y., Chen, Y. and Xie, R., 2025. Bibliometric analysis of immune-related acute kidney injury induced by cancer immunotherapy (2000\u20132025). Naunyn-Schmiedeberg's Arch Pharmacol, pp.1-16.","DOI":"10.1007\/s00210-025-04582-1"},{"key":"9844_CR34","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1186\/s40001-025-02734-w","volume":"30","author":"S Sadati","year":"2025","unstructured":"Sadati S, Khalaji A, Bonyad A, Khoshdooz S, HosseiniKolbadi KS, Bahrami A et al. NF-\u03baB and apoptosis: colorectal cancer progression and novel strategies for treatment. Eur J Med Res. 2025;30:616.","journal-title":"Eur J Med Res."},{"key":"9844_CR35","first-page":"659","volume":"53","author":"J Zhang","year":"2018","unstructured":"Zhang J, Shao S, Han D, Xu Y, Jiao D, Wu J et al. High mobility group box 1 promotes the epithelial-to-mesenchymal transition in prostate cancer PC3 cells via the RAGE\/NF-\u03baB signaling pathway. Int J Oncol. 2018;53:659\u2013671.","journal-title":"Int J Oncol."},{"key":"9844_CR36","doi-asserted-by":"publisher","first-page":"203","DOI":"10.2147\/JHC.S394074","volume":"10","author":"S Tang","year":"2023","unstructured":"Tang S, Xu B, Pang H, Xiao L, Mei Q, He X. Ozonated water inhibits hepatocellular carcinoma invasion and metastasis by regulating the HMGB1\/NF-\u03baB\/STAT3 signaling pathway. J Hepatocell Carcinoma. 2023;10:203\u2013215.","journal-title":"J Hepatocell Carcinoma."},{"key":"9844_CR37","doi-asserted-by":"publisher","first-page":"3893","DOI":"10.7150\/jca.42944","volume":"11","author":"Y Song","year":"2020","unstructured":"Song Y, Zou X, Zhang D, Liu S, Duan Z, Liu L. Self-enforcing HMGB1\/NF-\u03baB\/HIF-1\u03b1 feedback loop promotes cisplatin resistance in hepatocellular carcinoma cells. J Cancer. 2020;11:3893\u20133902.","journal-title":"J Cancer."},{"key":"9844_CR38","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1159\/000533927","volume":"101","author":"J Ma","year":"2023","unstructured":"Ma J, Da M. High-mobility group box 1 overexpression predicts a poor prognosis and promotes epithelial-mesenchymal transition in gastric cancer by activating TLR4\/NF-\u03baB signaling. Oncology. 2023;101:786\u2013798.","journal-title":"Oncology."},{"key":"9844_CR39","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.3892\/ijo.2014.2285","volume":"44","author":"J Zhang","year":"2014","unstructured":"Zhang J, Kou YB, Zhu JS, Chen WX, Li S. Knockdown of HMGB1 inhibits growth and invasion of gastric cancer cells through the NF-\u03baB pathway in vitro and in vivo. Int J Oncol. 2014;44:1268\u20131276.","journal-title":"Int J Oncol."}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-026-09844-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-026-09844-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-026-09844-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T03:01:08Z","timestamp":1787540468000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-026-09844-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,31]]},"references-count":39,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["9844"],"URL":"https:\/\/doi.org\/10.1007\/s10620-026-09844-3","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,31]]},"assertion":[{"value":"14 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflicts of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of Gansu Provincial Hospital according to the Declaration of Helsinki.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The patients grant the organizers the right to use pathological specimens for scientific research.","order":3,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}}]}}